跳至主要内容
临床试验/ISRCTN17726268
ISRCTN17726268已完成不适用

The efficacy and safety of intra-articular injections with the tumour-necrotising factor alpha (TNFa) antagonist infliximab in patients with chronic or recurrent arthritis of the knee

eiden University Medical Centre (LUMC) (The Netherlands)0 个研究点目标入组 40 人开始时间: 2005年12月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Inflammatory arthritis involving a knee (rheumatoid arthritis, juvenile chronic arthritis, spondylarthropathies and arthritis of unknown origin)
  • 2. Aged above 18 years
  • 3. Written informed consent
  • 4. At least two therapeutic corticosteroid injections in the affected joint within a period of one year

排除标准

  • 1. Haemorrhagic disease
  • 2. Arthritis due to infection, gout or osteoarthritis
  • 3. Participation in any other study which interferes with or is influenced by this study
  • 4. Use of oral prednisone in excess of 10 mg/day
  • 5. Recent change of disease modifying anti-inflammatory drug (DMARD) therapy (six weeks or less)
  • 6. Intra-articular injection with corticosteroid less than two months ago (concerning all joints)
  • 7. Hypersensitivity to methylprednisolone/triamcinolone, lidocain or infliximab (murine proteins) or intravenous (iv) contrast
  • 8. Active/latent tuberculosis
  • 9. Acute/chronic infection
  • 10. Multiple sclerosis
  • 11. Decompensation cordis (New York Heart Association [NYHA] classification III and IV)
  • 12. Pregnancy or lactating females
  • 13. Malignancy
  • 14. Claustrophobia
  • 15. Pacemaker in situ/metal prostheses and/or vascular clips

研究者

发起方
eiden University Medical Centre (LUMC) (The Netherlands)

相似试验

已完成
2 期
Safety and efficacy of intra-articular injections of platelet-rich plasma for the treatment of osteoarthritis of the knee in the Japanese populatioOsteoarthritis of the knee
JPRN-UMIN000011829niversity of Tsukuba Hospital10
招募中
不适用
The efficacy and safety of intra-articular injections with the TNF-a antagonist infliximab in patients with chronic or recurrent arthritis of the knee.recurrent or persistent inflammatory arthritis involving a knee (rheumatoid arthritis, juvenile chronic arthritis, spondylarthropathies and arthritis of unknown origin) despite corticosteroid injections intra-articular
NL-OMON24235department of rheumatologyLeids Universitair Medisch CentrumPostbus 9600 RC Leiden40
招募中
2 期
The effectiveness of Hyaluronic acid/Chondroitin injection on knee performance after surgical fixation.
IRCT20170608034390N13Shahid Beheshti University of Medical Sciences32
进行中(未招募)
1 期
Efficacy and safety of 3 intra-articular injections of 500 µg icatibant in a randomized, double-blind, parallel-group, placebo-controlled 13-week multi-centre study in patients with symptomatic knee osteoarthritis, continued by an observation of safety and tolerability over a further double-blind 13-week period - NApatients with painful OA in the knee
EUCTR2006-005946-35-SKsanofi-aventis recherche & développement450
已完成
不适用
Safety and performance of the intra-articular injection of animal-free chitosan biomaterial (viscosupplementation) in patients with symptomatic knee osteoarthritis: a pre-market studyArtrosis10023213Osteoarthritis
NL-OMON48771KiOmed PHARMA SA35
The efficacy and safety of intra-articular... | 临床试验